PTGFRN and cancer: Conjugation of the fully human anti‐PTGFRN antibody 8C7 to the payload Duocarmycin using a cleavable valine‐citrulline linker resulted in an ADC that demonstrated high efficacy in inhibiting cancer cell proliferation in in vitro models.